Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FENC Fennec Pharmaceuticals Inc.

盘前交易 05-01 08:49:53 EDT

6.49

+0.23

+3.67%

最高6.51	最低6.24	成交量14.92万
今开6.27	昨收6.26	日振幅4.31%
总市值2.24亿	流通市值1.48亿	总股本3,448万
成交额96.04万	换手率0.66%	流通股本2,275万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":6.49,"timestamp":1777579200000,"preClose":6.26,"halted":0,"volume":149238,"delay":0,"changeRate":0.036741214057508055,"floatShares":22750500,"shares":34475178,"eps":-0.340868,"marketStatus":"盘前交易","change":0.23,"latestTime":"05-01 08:49:53 EDT","open":6.27,"high":6.51,"low":6.24,"amount":960425.8633,"amplitude":0.043131,"askPrice":7.76,"askSize":100,"bidPrice":3.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.340868,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777642200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6.49,"postHourTrading":{"tag":"盘后","latestPrice":6.49,"preClose":6.49,"latestTime":"16:10 EDT","volume":5,"amount":32.45,"timestamp":1777579803988,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.5648060937462172,"impliedVol":2.042,"impliedVolPercentile":0.92},"requestUrl":"/m/hq/s/FENC","defaultTab":"news","newsList":[{"id":"1160185062","title":"Fennec制药宣布亚利桑那大学癌症中心将主导研究者发起研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1160185062","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160185062?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:03","pubTimestamp":1775559801,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals Inc.（简称Fennec制药）近日披露，由亚利桑那大学癌症中心主导的一项研究者发起研究（ISS）即将启动。该研究旨在探索公司核心疗法在临床实践中的潜在应用价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193669362","title":"Fennec制药公司达成和解协议：诉讼将获撤销，双方各自承担费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1193669362","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193669362?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:35","pubTimestamp":1773664501,"startTime":"0","endTime":"0","summary":"根据最新达成的和解条款，Fennec制药公司的法律纠纷即将画上句号。该诉讼将正式被法院撤销，且双方同意各自承担相关法律费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193575106","title":"Fennec制药宣布与坦帕综合医院癌症研究所达成临床研究合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1193575106","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193575106?lang=zh_cn&edition=full","pubTime":"2026-03-04 20:05","pubTimestamp":1772625949,"startTime":"0","endTime":"0","summary":"Fennec制药公司（Fennec Pharmaceuticals Inc.）近日宣布，已与坦帕综合医院癌症研究所（Tampa General Hospital Cancer Institute）建立临床研究合作伙伴关系。此次合作旨在共同推进癌症治疗领域的临床研究项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193774763","title":"Piper Sandler首予Fennec Pharmaceuticals Inc.增持评级，目标价18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193774763","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193774763?lang=zh_cn&edition=full","pubTime":"2026-01-09 12:44","pubTimestamp":1767933870,"startTime":"0","endTime":"0","summary":"投资银行Piper Sandler近日宣布，首次覆盖生物制药公司Fennec Pharmaceuticals Inc.，并给予“增持”评级。该机构为其设定的目标股价为18美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158731359","title":"Southpoint资本顾问公司持有Fennec 270万普通股，占流通股8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158731359","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158731359?lang=zh_cn&edition=full","pubTime":"2025-12-27 06:47","pubTimestamp":1766789234,"startTime":"0","endTime":"0","summary":"根据最新披露信息，Southpoint Capital Advisors已累计持有Fennec Pharmaceuticals Inc.（Fennec）270万股普通股。这一持股数量约占该公司流通普通股总数的8%，显示出该投资机构对Fennec未来发展前景的积极看好。\n此次股权变动凸显了机构投资者对生物制药领域的持续关注。作为专业投资管理机构，Southpoint的持股动向往往被视为市场风向标之一。值得注意的是，8%的持股比例已达到重要股权披露门槛，这通常意味着投资机构对企业战略价值的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119144752","title":"Fennec Pharmaceuticals公布日本Pedmark®临床研究积极初步结果，以降低顺铂引发的听力损失","url":"https://stock-news.laohu8.com/highlight/detail?id=1119144752","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119144752?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:02","pubTimestamp":1764676940,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals公布日本Pedmark®临床研究积极初步结果，以降低顺铂引发的听力损失","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506186302","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大涨5.94%报6.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506186302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506186302?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:19","pubTimestamp":1737994798,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时19分，Fennec Pharmaceuticals Inc.股票出现异动，股价快速上涨5.94%。截至发稿，该股报6.60美元/股，成交量13.3632万股，换手率0.49%，振幅5.94%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为2022.34%、480.67%、221.07%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为86.84%、85.35%、65.16%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012800195896124a17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012800195896124a17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505902557","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大涨5.76%报6.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505902557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505902557?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:31","pubTimestamp":1737664297,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时31分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速上涨5.76%。截至发稿，该股报6.06美元/股，成交量4.1096万股，换手率0.15%，振幅9.25%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.73%。其相关个股中，Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7451.49%、7397.01%、1156.33%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为948.57%、261.32%、172.73%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124043137abb6403d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124043137abb6403d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493795723","title":"Fennec Pharmaceuticals Inc.盘中异动 急速上涨5.08%报6.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493795723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493795723?lang=zh_cn&edition=full","pubTime":"2024-12-24 01:41","pubTimestamp":1734975677,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时41分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.08%。截至发稿，该股报6.29美元/股，成交量4.3792万股，换手率0.16%，振幅5.68%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为914.26%、870.40%、841.12%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.，振幅分别为157.37%、104.19%、96.28%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122401411895eade75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122401411895eade75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492100045","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.30%报5.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492100045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492100045?lang=zh_cn&edition=full","pubTime":"2024-12-20 03:00","pubTimestamp":1734634853,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日03时00分，Fennec Pharmaceuticals Inc.股票出现异动，股价快速拉升5.30%。截至发稿，该股报5.96美元/股，成交量3.7651万股，换手率0.14%，振幅6.54%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd.、Bio-Path Holdings, Inc.涨幅较大，Psyence Biomedical Ltd.、Bio-Path Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为8458.05%、2483.67%、624.65%，振幅较大的相关个股有Psyence Biomedical Ltd.、Bio-Path Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为396.08%、307.92%、249.61%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220030054a1fbc095&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220030054a1fbc095&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489752234","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨5.42%报6.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489752234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489752234?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:21","pubTimestamp":1733498462,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时21分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅上涨5.42%。截至发稿，该股报6.03美元/股，成交量8940股，换手率0.03%，振幅5.24%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232103971c275b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232103971c275b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489846850","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘大幅下挫5.16%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489846850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489846850?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:00","pubTimestamp":1733410850,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时00分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.16%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Molecular Templates, Inc.涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为2162.32%、316.51%、282.97%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Protara Therapeutics, Inc.，振幅分别为109.60%、84.26%、76.84%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523005198e59f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523005198e59f97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488064616","title":"Fennec Pharmaceuticals Inc.盘中异动 临近午盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488064616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488064616?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:53","pubTimestamp":1733158386,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时53分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.45%。截至发稿，该股报6.39美元/股，成交量11.4606万股，换手率0.42%，振幅6.93%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为2136.51%、2071.05%、256.14%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为481.02%、289.12%、64.17%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203005306abf04652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203005306abf04652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486964888","title":"Fennec Pharmaceuticals Inc.盘中异动 快速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486964888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486964888?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:51","pubTimestamp":1732636289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时51分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.30%。截至发稿，该股报5.96美元/股，成交量2.5162万股，换手率0.09%，振幅8.09%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Poseida Therapeutics, Inc.、Protagenic Therapeutics, Inc.、Ventyx Biosciences, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为36.62%、23.54%、21.21%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、34.09%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126235129971a8acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126235129971a8acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486403096","title":"Fennec Pharmaceuticals Inc.盘中异动 急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486403096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486403096?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:45","pubTimestamp":1732553116,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时45分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速拉升5.08%。截至发稿，该股报5.59美元/股，成交量6.8801万股，换手率0.25%，振幅8.36%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.65%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Exicure, Inc.涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为124.22%、104.78%、79.50%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.，振幅分别为95.05%、81.74%、75.84%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126004516abde38ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126004516abde38ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484148403","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148403?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:59","pubTimestamp":1732114756,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时59分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.03%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为933.70%、416.57%、167.47%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为183.66%、102.78%、65.87%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225916abd23fb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225916abd23fb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484854813","title":"Fennec Pharmaceuticals Inc.2024财年第三财季实现净利润-5.74百万美元，同比减少206.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484854813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484854813?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772991,"startTime":"0","endTime":"0","summary":"11月17日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2024财年第三财季净利润为-5.74百万美元，同比减少206.95%；其中营业收入为6.97百万美元，同比增加6.90%，每股基本收益为-0.21美元。机构评级：截至2024年11月17日，当前有4家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为13.25美元，其中最低目标价为12.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000416abc79099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000416abc79099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483396378","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483396378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483396378?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:29","pubTimestamp":1731515396,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时29分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅上涨5.44%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为481.74%、286.13%、103.74%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为88.00%、67.77%、46.01%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002956a2349b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002956a2349b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481198320","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.00%报5.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481198320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481198320?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903428,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报5.04美元/股，成交量363股，换手率0.00%，振幅0.00%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Macrogenics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Syndax Pharmaceuticals, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1007.84%、97.66%、46.60%，振幅较大的相关个股有Nurix Therapeutics, Inc.、Ocular Therapeutix, Inc.、诺瓦瓦克斯医药，振幅分别为104.05%、103.88%、96.82%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622302898e40d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622302898e40d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481536522","title":"Fennec Pharmaceuticals Inc.盘中异动 临近午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481536522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481536522?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:33","pubTimestamp":1730738004,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时33分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速上涨5.07%。截至发稿，该股报4.56美元/股，成交量2.4769万股，换手率0.09%，振幅6.22%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为322.05%、272.26%、73.27%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003324971a4372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003324971a4372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0553},{"period":"3month","weight":-0.1449},{"period":"6month","weight":-0.2085},{"period":"1year","weight":0.0745},{"period":"ytd","weight":-0.1571}],"compareEarnings":[{"period":"1week","weight":0.0144},{"period":"1month","weight":0.1051},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0537},{"period":"1year","weight":0.296},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fennec Pharmaceuticals Inc.于1996年9月根据《加拿大商业公司法》注册成立，并于2011年8月25日根据《商业公司法》重新注册成立。该公司是一家商业化阶段的专业制药公司，致力于预防顺铂引起的耳毒性。其产品PEDMARK已在美国及其他市场获批，用于降低接受顺铂治疗的局部实体瘤儿科患者听力损失的风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.007938},{"month":2,"riseRate":0.666667,"avgChangeRate":0.036719},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.061428},{"month":4,"riseRate":0.555556,"avgChangeRate":-0.011347},{"month":5,"riseRate":0.375,"avgChangeRate":0.015787},{"month":6,"riseRate":0.5,"avgChangeRate":0.019295},{"month":7,"riseRate":0.625,"avgChangeRate":0.025783},{"month":8,"riseRate":0.5,"avgChangeRate":-0.033993},{"month":9,"riseRate":0.625,"avgChangeRate":0.038197},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.018349},{"month":11,"riseRate":0.666667,"avgChangeRate":0.041126},{"month":12,"riseRate":0.555556,"avgChangeRate":0.027685}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}